Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer.
Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer. Breast Cancer Res. 2018 06 14; 20(1):50.